<!doctype html>
<html lang="en">
  <head>
    <!-- Required meta tags -->
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

    <!-- Bootstrap CSS -->
    <link rel="preconnect" href="https://fonts.gstatic.com">
    <link href="https://fonts.googleapis.com/css2?family=Montserrat:wght@100;200;300;400;500;600;700;800;900&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="css/bootstrap.min.css">
    <link rel="stylesheet" href="css/style.css">

    <title>Agios</title>
  </head>
  <body>
    <nav class="navbar navbar-expand-lg navbar-dark">
      <div class="container">
        <a class="navbar-brand" href="index.html">
          <img src="images/logo.png" />
        </a>

        <ul class="navbar-nav ml-auto">
            <li class="nav-item active">
              <a class="nav-link" href="index.html">
                <img src="images/icons/home-icon.png" width="30">
              </a>
            </li>
            <li class="nav-item active">
              <a class="nav-link" href="peak-registry.html">
                <img src="images/icons/peak-registry-icon.png" width="30">
              </a>
            </li>
            <li class="nav-item active">
              <a class="nav-link" href="pkr-activator-pipeline.html">
                <img src="images/icons/pipeline-icon.png" width="30">
              </a>
            </li>
          </ul>
      </div>
    </nav>
    <main class="pipeline-details">
      <div class="container">
        <div class="row">
          <div class="col-sm-9 col-7">
            <h1 class="mb-4">Mitapivat Pipeline Overview <img class="activate" src="images/activate.png"></h1>
          </div>

          <div class="col-sm-3 col-5">
            <span class="badge red-dark float-right mt-1">Status: Completed</span>
          </div>
        </div>
        <div class="row">
            <div class="col-md-8">
              <h4 class="font-weight-normal red-text mb-3"><strong>ACTIVATE:</strong> A phase 3 trial studying the investigational drug, mitapivat, in adult patients with PK deficiency who are <strong>not regularly transfused<sup>1</sup></strong></h4>
              
              <div class="block">
                <img src="images/mitapivat-pipeline-overview-activate.png" />
                <p><strong class="red-text">Primary Efficacy Endpoint:</strong><br/>
                Proportion of patients who achieve at least a 1.5 g/dL increase in hemoglobin sustained over  visits in the Optimized Dose Period.</p>
              </div>
            </div>
            <div class="col-md-4">
              <div class="block side-block-container">
                <div class="side-block">
                  <p class="mb-1"><strong>Patient Population</strong></p>
                  <ul class="mb-0 pl-20">
                      <li>Not regularly transfused adults</li>
                      <li>Baseline hemoglobin of ≤10.0 grams per deciliter</li>
                      <li>Excludes patients with two non-missense mutations and those homozygous for R479H</li>
                  </ul>
                </div>
                <div class="side-block side-block-gray">
                  <p class="mb-1"><strong>Dose</strong></p>
                  <ul class="mb-0 pl-20">
                      <li>Dose titration up to optimal hemoglobin response (5, 20 or 50 mg twice daily)</li>
                  </ul>
                </div>
                <div class="side-block">
                  <p class="mb-1"><strong>Endpoints</strong></p>
                  <ul class="mb-0 pl-20">
                      <li>Hemoglobin response</li>
                      <li>Safety</li>
                      <li>Patient-reported outcomes (PRO)</li>
                  </ul>
                </div>
                <div class="side-block side-block-gray">
                  <p class="mb-1"><strong>Control</strong></p>
                  <ul class="mb-0 pl-20">
                      <li>Placebo controlled</li>
                  </ul>
                </div>
                <div class="side-block">
                </div>
              </div>
            </div>
        </div>
        <footer>
            <div class="row">
              <div class="col-md-12">
                <p class="text-left mb-4">1≤ 4 transfusion episodes in the 12-month period up to the first day of study treatment, and no transfusions in the 3 months prior to the first dose<br/>
                *The safety and efficacy of mitapivat has not been established. There is no guarantee that mitapivat will receive health authority approval or become commercially available in any country for the uses being investigated.</p>
                <p class="text-right">For more information (physician/HCP only),<br/>
                please email medinfo@agios.com<br/>
                &copy;2021 Agios Pharmaceuticals, Inc. All rights reserved.</p>
              </div>
            </div>
        </footer>
      </div>
    </main>


    <!-- Optional JavaScript -->
    <!-- jQuery first, then Popper.js, then Bootstrap JS -->
    <!-- <script src="https://code.jquery.com/jquery-3.2.1.slim.min.js" integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.12.9/umd/popper.min.js" integrity="sha384-ApNbgh9B+Y1QKtv3Rn7W3mgPxhU9K/ScQsAP7hUibX39j7fakFPskvXusvfa0b4Q" crossorigin="anonymous"></script> -->
    <script src="js/jquery-3.4.1.min.js"></script>
    <script src="js/bootstrap.min.js"></script>
  </body>
</html>